key: cord-0696358-m3wklmp7
authors: Bendavid, Eran; Oh, Christopher; Bhattacharya, Jay; Ioannidis, John P.A.
title: Authors Response to Letters to the editor regarding: ‘Assessing mandatory stay‐ At‐ Home and business closure effects on the spread of COVID‐ 19’
date: 2021-03-29
journal: Eur J Clin Invest
DOI: 10.1111/eci.13553
sha: be363c5eb2895e99a753ca0501b277d84e19b536
doc_id: 696358
cord_uid: m3wklmp7

We are pleased to see the active discussion around our study on the relationship between mandatory stay- at- home and business closures and COVID-19 spread.1 In this response, we address issues raised in three letters.2-4 The claim that the study had sample size of n=10 countries is incorrect.2 Each of the 16 regression models represented in Figure 4 included, on average, 1,362 data points (range 771-3,493) on 52 subnational units (range 27-129). Each panel regression is, in effect, a "mini-meta-analysis": the effect size is evaluated within each subnational unit, and the overall effect size is estimated from a pooling of these "within" effects. So while we aggregated the results to 10 countries, the sample size is not n=10.

The claim that the study had sample size of n = 10 countries is incorrect. 2 Each of the 16 regression models represented in Figure 4 included, on average, 1362 data points (range 771-3493) on 52 subnational units (range 27-129). Each panel regression is, in effect, a 'mini-meta-analysis': the effect size is evaluated within each subnational unit, and the overall effect size is estimated from a pooling of these 'within' effects. So, while we aggregated the results to 10 countries, the sample size is not n = 10.

In contrast to the suggestions in the letters, we left countries such as Denmark and New Zealand out not because they would demonstrate patterns that would support the role of restrictive measures, but exactly because the paltry spread of COVID-19 in these countries would prevent learning anything meaningful about the role of NPIs in these countries. 2 We anticipated separability challenges in identifying any nonpharmaceutical intervention's (NPI) effect when analysing changes in growth rates from a baseline of little (or, in many subnational units, no) growth. In our regression framework, no NPI would likely show a meaningful effect in Denmark or New Zealand where case growth rate was low, both before and after NPIs were implemented (hence no meaningful changes in case growth). We could have noted ex ante that we selected countries with more meaningful virus spread, though we do note that 'Additional countries could provide more evidence, especially countries that had meaningful epidemic penetration'.

For countries like New Zealand with tepid epidemic growth, it is statistically and intuitively apparent that teasing apart which, among all the measures implemented, had worked is impossible. Viral entry and spread in New Zealand was limited relative to the United States, and more amenable to control. Less restrictive NPIs may well have been sufficient to maintain epidemic control. Some suggest that New Zealand's effective control can be ascribed to its highly restrictive lockdowns. 5 That opinion, unfortunately, has no evidence to support it beyond the anecdotal. As of March 2021, the highest death rates globally have occurred in countries that used prolonged and very restrictive measures, while the lowest death rates occurred in countries with more diverse responses. This is of course no proof of the futility of lockdowns, but it does call into question any claims of a much-worse counterfactual with less restrictive measures.

Experience from past pandemics has shown vast differences in disease spread across different locations, irrespective of measures taken, and we are seeing the same variability with COVID-19. Ignoring these plain-to-see epidemiologic patterns is a disservice to public health and society.

In terms of country selection, our analysis examines 4 countries more than the analysis after which it is fashioned (1.7×) and 2 countries less than a prominent, but problematic, modelling study of lockdown effects (0.8×). [6] [7] [8] [9] We invite any researchers to add countries to our analysis: we made all the code available in large part for this exact reason.

The comparisons we use are not 'arbitrary'. 2 The distinction we made between more and less restrictive NPIs is a meaningful one, and it characterizes the study countries well. Idiosyncratic differences in implementation of various NPIs exist in all analyses evaluating the effectiveness of NPIs, including those that find favourable results for more restrictive measures. LETTER Fuchs worries about omitting the period of declining daily case numbers, but this is a misunderstanding. 4 We measure growth of cumulative cases, which are monotonically increasing, and therefore never go below 0 (negative growth) in our study's figure 1 ("Growth rate in cases for study countries"). The data that we include cover the period up to the elimination of rapid growth in the first wave ( Figure 1 ).

We would like to provide additional (hopefully clarifying) detail related to our statistical models. The binary Policy pcit variables represent a set of indicators, each identifying an NPI (one for each NPI implemented in each subnational unit in each country), which changes value from 0 to 1 after the policy is implemented and for the policy's duration. The variable construction is equivalent to interacting the policy indicator with a 'post' time variable for each policy. 3 We implement panel regression models where the coefficients on the Policy pcit variables identify 'breaks' in case growth patterns in each subnational unit following the implementation of each NPI identified by the specific Policy pcit variables, rather than a difference-in-difference as suggested by Chini. 3 We analyse every pair of countries with more and less restrictive measures. For each regression, we include a full set of district-level binary dummy variables (θ 0,ci ) for both countries in each model. These dummies remove the influence of time-invariant differences between districts and countries on the overall effect size. In addition, we also include day-ofweek binary dummies δ ct that are unique to each country.

Rather than impose strong assumptions about the similarity between countries, our approach is to examine every pairwise comparison of countries that have adopted more or less restrictive measures. Thus, each regression model includes two countries-one with and one without more restrictive measures-each represented by the 'c' index that Chini found objectionable. 3 We do not pass a strong verdict on the role of parallel trends assumptions for causal identification here, but note that if it were indeed critical, that would invalidate most assessments of NPI effects that use similar econometric approaches, since the baseline trends are unique and highly nonlinear in each subnational unit. 6 We note that, by mistake, we cumulated the case counts for the Netherlands twice. Correcting this, the trend for the Netherlands points more strongly to enhanced case spread with more restrictive measures (0.08 (0.00-0.17) vs Sweden and 0.13 (−0.11-0.37) vs South Korea).

We share concerns for confounding in analyses of observational data. However, possible confounding cuts in both directions. For example, in 9 out of 10 countries, we find a reduction in case spread following 'all NPIs', but even this beneficial effect could be due to confounding. Similarly, one may speculate whether our finding of a negative effect size in Iran could be accounted for by inclusion of an 'authoritarian regime' variable. 10 The issue of lags and timing seems to be a common concern, but makes no difference to the findings or interpretation. The timing of each NPI in each subnational unit of each country is explicitly modelled in the Policy pcit variables. Introducing a lag does not alter any of the principal findings: those findings are driven by the similarity in the growth patterns of case counts between the compared countries, irrespective of any lags. We invite the letter-writers (and others) to introduce sensible lags into the statistical models and rerun the analyses (code and data are publicly available).

Fuchs' discussion of the effect size is incorrect. The lowest bound of the most favourable comparison for restrictive NPIs (Iran vs. South Korea) is −0.28 (about 25% reduction over the entire period of the first wave when converted back from natural log scale; estimates from the study's figure 4) . That is, the data suggest it is not very implausible that Iran's restrictive measures account for an additional 25% reduction in case growth over the entire period in comparison with South Korea. The data also suggest it is not very implausible that more restrictive measures account for upwards of 40% increase in case growth over the period in the United States, Spain and England. The negative extreme bounds should be emphasized no more than the positive extreme bounds.

An underlying theme in the letters is that COVID-19's epidemic trajectories have been difficult to characterize, and have traced trajectories that often seem disconnected from the policies aimed at modifying these trajectories. 11 This introduces large uncertainties into any assessment of NPI effects. A recent modelling study illustrates the oscillatory epidemic dynamics under adaptive behaviour changes, underscoring the deeply endogenous relationship between behaviours and epidemic waves. 12 Policies, in that scheme, have a modulating impact of unknown extent on the realized epidemic patterns. The past year has revealed puzzling patterns of epidemic dynamics that have defied models that attribute much epidemic control to policies. 13 At the time of this writing, cases and deaths are declining across most US locations, despite models' predictions to the contrary. 14 This points to a more generalized and pernicious challenge: how should NPI effects be studied? Simulation models are clearly problematic because their results are a direct function of input assumptions. Observational studies, especially using causal inference methods, have advantages. However, when the underlying dynamics are nonlinear and the policies are deeply endogenous, as in this case, attribution is precarious. This limitation is shared by all observational assessments | 3 of 3 LETTER of NPI effects. 6, 15, 16 Randomization has been increasingly used for assessing the impact of real-world policies, and the value of knowing the benefits of NPIs, especially those with large health and welfare costs, would be enormous. 17 In all, we maintain that the science plausibly supports beneficial, null or harmful impacts on epidemic outcomes of highly restrictive measures, such as mandatory stay-at-home and business closures. Given their many uncontestable harms to health and society, we believe that the extant literature does not provide strong support for their effectiveness at reducing case spread, and should be subjected to careful, critical and rigorous evaluation. If the benefits of such measures are negligible (or worse), their perpetuation may be, on balance, detrimental to the health of the public.

Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19

Sample size, timing, and other confounding factors: toward a fair assessment of stay-at home orders

Letter to Editor

Ioannidis JPA Assessing mandatory stay-at-home and business closure effects on the spread of covid-19

New Zealand eliminates COVID-19

The effect of largescale anti-contagion policies on the COVID-19 pandemic

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

The effect of interventions on COVID-19

The limits of estimating COVID-19 intervention effects using Bayesian models

America's two largest states are fighting covid-19 differently. The Economist

Adaptive social contact rates induce complex dynamics during epidemics

Learning as We Go: An Examination of the Statistical Accuracy of COVID19 Daily Death Count Predictions

Why Vaccines Alone Will Not End the Pandemic. The New York Times

Causal impact of masks, policies, behavior on early covid-19 pandemic in the U

Inferring the effectiveness of government interventions against COVID-19

Preserving equipoise and performing randomised trials for COVID-19 social distancing interventions